Novel N-terminal Cleavage of APP Precludes Aβ Generation in ACAT-Defective AC29 Cells (original) (raw)

References

• Abad-Rodriguez, J., Ledesma, M. D., Craessaerts, K., Perga, S., Medina, M., Delacourte, A., et al. (2004). Neuronal membrane cholesterol loss enhances amyloid peptide generation. Journal of Cell Biology, 167, 953–960. doi:10.1083/jcb.200404149.
  Article PubMed CAS Google Scholar
• Abbenante, G., Kovacs, D. M., Leung, D. L., Craik, D. J., Tanzi, R. E., & Fairlie, D. P. (2000). Inhibitors of beta-amyloid formation based on the beta-secretase cleavage site. Biochemical and Biophysical Research Communications, 268, 133–135. doi:10.1006/bbrc.2000.2098.
  Article PubMed CAS Google Scholar
• Boerwinkle, E., Visvikis, S., Welsh, D., Steinmetz, J., Hanash, S. M., & Sing, C. F. (1987). The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, beta-lipoprotein, and triglycerides in a sample of unrelated individuals. American Journal of Medical Genetics, 27, 567–582. doi:10.1002/ajmg.1320270310.
  Article PubMed CAS Google Scholar
• Brown, M. S., & Goldstein, J. L. (1999). A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proceedings of the National Academy of Sciences of the United States of America, 96, 11041–11048. doi:10.1073/pnas.96.20.11041.
  Article PubMed CAS Google Scholar
• Burns, M., Gaynor, K., Olm, V., Mercken, M., LaFrancois, J., Wang, L., et al. (2003). Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo. Journal of Neuroscience, 23, 5645–5649.
  PubMed CAS Google Scholar
• Cadigan, K. M., Heider, J. G., & Chang, T. Y. (1988). Isolation and characterization of Chinese hamster ovary cell mutants deficient in acyl-coenzyme A:cholesterol acyltransferase activity. Journal of Biological Chemistry, 263, 274–282.
  PubMed CAS Google Scholar
• Chang, T. Y., Chang, C. C., Ohgami, N., & Yamauchi, Y. (2006). Cholesterol sensing, trafficking, and esterification. Annual Review of Cell and Developmental Biology, 22, 129–157. doi:10.1146/annurev.cellbio.22.010305.104656.
  Article PubMed CAS Google Scholar
• Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families [see comments]. Science, 261, 921–923. doi:10.1126/science.8346443.
  Article PubMed CAS Google Scholar
• Cutler, R. G., Pedersen, W. A., Camandola, S., Rothstein, J. D., & Mattson, M. P. (2002). Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Annals of Neurology, 52, 448–457. doi:10.1002/ana.10312.
  Article PubMed CAS Google Scholar
• Ehnholm, C., Lukka, M., Kuusi, T., Nikkila, E., & Utermann, G. (1986). Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. Journal of Lipid Research, 27, 227–235.
  PubMed CAS Google Scholar
• Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lutjohann, D., Keller, P., et al. (2001). Simvastatin strongly reduces levels of Alzheimer’s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America, 98, 5856–5861. doi:10.1073/pnas.081620098.
  Article PubMed CAS Google Scholar
• Fitzky, B. U., Moebius, F. F., Asaoka, H., Waage-Baudet, H., Xu, L., Xu, G., et al. (2001). 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. Journal of Clinical Investigation, 108, 905–915.
  PubMed CAS Google Scholar
• Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H., & Austen, B. M. (1999). The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport, 10, 1699–1705. doi:10.1097/00001756-199906030-00014.
  Article PubMed CAS Google Scholar
• Glenner, G. G., & Wong, C. W. (1984). Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications, 120, 885–890. doi:10.1016/S0006-291X(84)80190-4.
  Article PubMed CAS Google Scholar
• Grimm, M. O., Grimm, H. S., Patzold, A. J., Zinser, E. G., Halonen, R., Duering, M., et al. (2005). Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nature Cell Biology, 7, 1118–1123.
  Article PubMed CAS Google Scholar
• Haass, C. (2004). Take five-BACE and the gamma-secretase quartet conduct Alzheimer’s amyloid beta-peptide generation. EMBO Journal, 23, 483–488. doi:10.1038/sj.emboj.7600061.
  Article PubMed CAS Google Scholar
• Hutter-Paier, B., Huttunen, H. J., Puglielli, L., Eckman, C. B., Kim, D. Y., Hofmeister, A., et al. (2004). The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer’s disease. Neuron, 44, 227–238. doi:10.1016/j.neuron.2004.08.043.
  Article PubMed CAS Google Scholar
• Huttunen, H. J., Greco, C., & Kovacs, D. M. (2007a). Knockdown of ACAT-1 reduces amyloidogenic processing of APP. FEBS letters, 581, 1688–1692. doi:10.1016/j.febslet.2007.03.056.
  Article PubMed CAS Google Scholar
• Huttunen, H. J., Guenette, S. Y., Peach, C., Greco, C., Xia, W., Kim, D. Y., et al. (2007b). HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation. Journal of Biological Chemistry, 282, 28285–28295. doi:10.1074/jbc.M702951200.
  Article PubMed CAS Google Scholar
• Jarvik, G. P., Wijsman, E. M., Kukull, W. A., Schellenberg, G. D., Yu, C., & Larson, E. B. (1995). Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer’s disease: a case-control study. Neurology, 45, 1092–1096 Medline.
  PubMed CAS Google Scholar
• Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S., & Drachman, D. A. (2000). Statins and the risk of dementia. Lancet, 356, 1627–1631. doi:10.1016/S0140-6736(00)03155-X.
  Article PubMed CAS Google Scholar
• Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., et al. (1987). The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325, 733–736. doi:10.1038/325733a0.
  Article PubMed CAS Google Scholar
• Koudinov, A. R., Berezov, T. T., Kumar, A., & Koudinova, N. V. (1998). Alzheimer’s amyloid beta interaction with normal human plasma high density lipoprotein: Association with apolipoprotein and lipids. Clinica Chimica Acta, 270, 75–84. doi:10.1016/S0009-8981(97)00207-6.
  Article CAS Google Scholar
• Kuo, Y. M., Emmerling, M. R., Bisgaier, C. L., Essenburg, A. D., Lampert, H. C., Drumm, D., et al. (1998). Elevated low-density lipoprotein in Alzheimer’s disease correlates with brain A beta 1–42 levels. Biochemical and Biophysical Research Communications, 252, 711–715. doi:10.1006/bbrc.1998.9652.
  Article PubMed CAS Google Scholar
• Lee, S. J., Liyanage, U., Bickel, P. E., Xia, W., Lansbury Jr., P. T., & Kosik, K. S. (1998). A detergent-insoluble membrane compartment contains A beta in vivo. Nature Medicine, 4, 730–734. doi:10.1038/nm0698-730.
  Article PubMed CAS Google Scholar
• Liu, Q., Zerbinatti, C. V., Zhang, J., Hoe, H. S., Wang, B., Cole, S. L., et al. (2007). Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron, 56, 66–78. doi:10.1016/j.neuron.2007.08.008.
  Article PubMed CAS Google Scholar
• Murata, M., Peranen, J., Schreiner, R., Wieland, F., Kurzchalia, T. V., & Simons, K. (1995). VIP21/caveolin is a cholesterol-binding protein. Proceedings of the National Academy of Sciences of the United States of America, 92, 10339–10343. doi:10.1073/pnas.92.22.10339.
  Article PubMed CAS Google Scholar
• Notkola, I. L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., et al. (1998). Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer’s disease. Neuroepidemiology, 17, 14–20. doi:10.1159/000026149.
  Article PubMed CAS Google Scholar
• Parkin, E. T., Hussain, I., Karran, E. H., Turner, A. J., & Hooper, N. M. (1999). Characterization of detergent-insoluble complexes containing the familial Alzheimer’s disease-associated presenilins. Journal of Neurochemistry, 72, 1534–1543. doi:10.1046/j.1471-4159.1999.721534.x.
  Article PubMed CAS Google Scholar
• Podlisny, M. B., Tolan, D. R., & Selkoe, D. J. (1991). Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer’s disease. American Journal of Pathology, 138, 1423–1435.
  PubMed CAS Google Scholar
• Porter, J. A., Young, K. E., & Beachy, P. A. (1996). Cholesterol modification of hedgehog signaling proteins in animal development [see comments] [published erratum appears in Science 1996 Dec 6;274(5293):1597]. Science, 274, 255–259. doi:10.1126/science.274.5285.255.
  Article PubMed CAS Google Scholar
• Puglielli, L., Konopka, G., Pack-Chung, E., Ingano, L. A., Berezovska, O., Hyman, B. T., et al. (2001). Acyl-coenzyme A: Cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nature Cell Biology, 3, 905–912. doi:10.1038/ncb1001-905.
  Article PubMed CAS Google Scholar
• Puglielli, L., Tanzi, R. E., & Kovacs, D. M. (2003). Alzheimer’s disease: The cholesterol connection. Nature Neuroscience, 6, 345–351. doi:10.1038/nn0403-345.
  Article PubMed CAS Google Scholar
• Refolo, L. M., Wittenberg, I. S., Friedrich Jr., V. L., & Robakis, N. K. (1991). The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton. Journal of Neuroscience, 11, 3888–3897.
  PubMed CAS Google Scholar
• Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., et al. (2000). Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiology of Disease, 7, 321–331. doi:10.1006/nbdi.2000.0304.
  Article PubMed CAS Google Scholar
• Refolo, L. M., Pappolla, M. A., LaFrancois, J., Malester, B., Schmidt, S. D., Thomas-Bryant, T., et al. (2001). A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer’s disease. Neurobiology of Disease, 8, 890–899. doi:10.1006/nbdi.2001.0422.
  Article PubMed CAS Google Scholar
• Runz, H., Rietdorf, J., Tomic, I., de Bernard, M., Beyreuther, K., Pepperkok, R., et al. (2002). Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. Journal of Neuroscience, 22, 1679–1689.
  PubMed CAS Google Scholar
• Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., et al. (1993). Increased amyloid ß-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 90, 9649–9653. doi:10.1073/pnas.90.20.9649.
  Article PubMed CAS Google Scholar
• Sever, N., Yang, T., Brown, M. S., Goldstein, J. L., & DeBose-Boyd, R. A. (2003). Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Molecular Cell, 11, 25–33. doi:10.1016/S1097-2765(02)00822-5.
  Article PubMed CAS Google Scholar
• Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., & Simons, K. (1998). Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America, 95, 6460–6464. doi:10.1073/pnas.95.11.6460.
  Article PubMed CAS Google Scholar
• Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A., St George-Hyslop, P., Van Keuren, M. L., et al. (1987). Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science, 235, 880–884. doi:10.1126/science.2949367.
  Article PubMed CAS Google Scholar
• Thiele, C., Hannah, M. J., Fahrenholz, F., & Huttner, W. B. (2000). Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nature Cell Biology, 2, 42–49. doi:10.1038/71366.
  Article PubMed CAS Google Scholar
• Wollmer, M. A., Streffer, J. R., Tsolaki, M., Grimaldi, L. M., Lutjohann, D., Thal, D., et al. (2003). Genetic association of acyl-coenzyme A: Cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer’s disease. Molecular Psychiatry, 8, 635–638. doi:10.1038/sj.mp.4001296.
  Article PubMed CAS Google Scholar
• Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G. G., & Siegel, G. (2000). Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Archives of Neurology, 57, 1439–1443. doi:10.1001/archneur.57.10.1439.
  Article PubMed CAS Google Scholar
• Yang, T., Espenshade, P. J., Wright, M. E., Yabe, D., Gong, Y., Aebersold, R., et al. (2002). Crucial step in cholesterol homeostasis: Sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell, 110, 489–500. doi:10.1016/S0092-8674(02)00872-3.
  Article PubMed CAS Google Scholar

Download references